BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37140610)

  • 61. Cancer-associated stroma reveals prognostic biomarkers and novel insights into the tumour microenvironment of colorectal cancer and colorectal liver metastases.
    Brown KM; Xue A; Smith RC; Samra JS; Gill AJ; Hugh TJ
    Cancer Med; 2022 Jan; 11(2):492-506. PubMed ID: 34874125
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An elevated preoperative cholesterol-to-lymphocyte ratio predicts unfavourable outcomes in colorectal cancer liver metastasis patients receiving simultaneous resections: a retrospective study.
    Deng Y; Chen Q; Chen J; Zhang Y; Zhao J; Bi X; Li Z; Zhang Y; Huang Z; Cai J; Zhao H
    BMC Surg; 2023 May; 23(1):131. PubMed ID: 37194000
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expanding indications for laparoscopic parenchyma-sparing resection of posterosuperior liver segments in patients with colorectal metastases: comparison with open hepatectomy for immediate and long-term outcomes.
    Efanov M; Granov D; Alikhanov R; Rutkin I; Tsvirkun V; Kazakov I; Vankovich A; Koroleva A; Kovalenko D
    Surg Endosc; 2021 Jan; 35(1):96-103. PubMed ID: 31932927
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
    Tsuchihashi K; Ito M; Moriwaki T; Fukuoka S; Taniguchi H; Takashima A; Kumekawa Y; Kajiwara T; Yamazaki K; Esaki T; Makiyama A; Denda T; Satake H; Suto T; Sugimoto N; Katsumata K; Ishikawa T; Kashiwada T; Oki E; Komatsu Y; Okuyama H; Sakai D; Ueno H; Tamura T; Yamashita K; Kishimoto J; Shimada Y; Baba E
    Clin Colorectal Cancer; 2018 Dec; 17(4):e687-e697. PubMed ID: 30149986
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Preoperative leukocytosis is an independent risk factor for morbidity and survival after resection of colorectal liver metastases.
    Schnitzler LJ; Oldhafer F; Kulik U; Klempnauer J; Reese T; Oldhafer KJ; Beetz O
    ANZ J Surg; 2022 Oct; 92(10):2551-2559. PubMed ID: 35723493
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preoperative change of modified Glasgow prognostic score after stenting predicts the long-term outcomes of obstructive colorectal cancer.
    Sato R; Oikawa M; Kakita T; Okada T; Abe T; Yazawa T; Tsuchiya H; Akazawa N; Sato M; Ohira T; Harada Y; Okano H; Ito K; Ohuchi N; Tsuchiya T
    Surg Today; 2020 Mar; 50(3):232-239. PubMed ID: 31407166
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.
    Shimura T; Toiyama Y; Saigusa S; Imaoka H; Okigami M; Fujikawa H; Hiro J; Kobayashi M; Ohi M; Araki T; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Int J Clin Oncol; 2017 Aug; 22(4):758-766. PubMed ID: 28299463
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
    Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L
    BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study.
    Chen Q; Zhang R; Xing B; Li C; Xiu D; Chen J; Deng Y; Chen X; Guo R; Chen F; Peng J; Sun T; Wang H; Li M; Zheng Q; Bi X; Zhao J; Zhou J; Li Z; Huang Z; Zhang Y; Zhang Y; Cai J; Zhao H
    Int J Surg; 2022 Oct; 106():106952. PubMed ID: 36220519
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bilobar spreading of colorectal liver metastases does not significantly affect survival after R0 resection in the era of interdisciplinary multimodal treatment.
    Homayounfar K; Bleckmann A; Conradi LC; Sprenger T; Beissbarth T; Lorf T; Niessner M; Sahlmann CO; Meller J; Becker H; Liersch T; Ghadimi BM
    Int J Colorectal Dis; 2012 Oct; 27(10):1359-67. PubMed ID: 22430890
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Usefulness of Inflammation-Based Prognostic Scores for Predicting the Risk of Complications After Radical Resection of Colorectal Carcinoma.
    Man W; Lin H; Liu Z; Jin L; Wang J; Zhang J; Bai Z; Yao H; Zhang Z; Deng W
    Cancer Manag Res; 2020; 12():1029-1038. PubMed ID: 32104084
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The modified Glasgow Prognostic Score indicates an increased risk of anastomotic leakage after anterior resection for rectal cancer.
    Golshani P; Park J; Häggström J; Segelman J; Matthiessen P; Lydrup ML; Rutegård M;
    Int J Colorectal Dis; 2023 Jul; 38(1):200. PubMed ID: 37470911
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Resection of liver metastases from colorectal mucinous adenocarcinoma: is this a different disease? Results of a case-control study.
    Viganò L; Russolillo N; Ferrero A; De Rosa G; Ferreri E; Forchino F; Sperti E; Capussotti L
    Ann Surg; 2014 Nov; 260(5):878-84; discussion 884-5. PubMed ID: 25379857
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
    Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-platelet therapy does not influence the outcome of patients undergoing hepatic resection for colorectal liver metastases, an observational study.
    Boyd-Carson H; Irving G; Navarro AP; Cameron IC; Gomez DS;
    Int J Surg; 2018 May; 53():59-64. PubMed ID: 29555531
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.
    Nie D; Zhang L; Wang C; Guo Q; Mao X
    Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Multicentre propensity score-matched study of laparoscopic versus open repeat liver resection for colorectal liver metastases.
    van der Poel MJ; Barkhatov L; Fuks D; Berardi G; Cipriani F; Aljaiuossi A; Lainas P; Dagher I; D'Hondt M; Rotellar F; Besselink MG; Aldrighetti L; Troisi RI; Gayet B; Edwin B; Abu Hilal M
    Br J Surg; 2019 May; 106(6):783-789. PubMed ID: 30706451
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of the C-reactive protein to albumin ratio on long-term outcomes after hepatic resection for colorectal liver metastases.
    Haruki K; Shiba H; Horiuchi T; Sakamoto T; Gocho T; Fujiwara Y; Furukawa K; Misawa T; Yanaga K
    Am J Surg; 2017 Oct; 214(4):752-756. PubMed ID: 28187858
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
    Margonis GA; Buettner S; Andreatos N; Sasaki K; Ijzermans JNM; van Vugt JLA; Pawlik TM; Choti MA; Cameron JL; He J; Wolfgang CL; Weiss MJ
    Ann Surg; 2017 Oct; 266(4):641-649. PubMed ID: 28657938
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic significance of the preoperative lymphocyte to C-reactive protein ratio in patients with stage III colorectal cancer.
    Eren T
    ANZ J Surg; 2022 Oct; 92(10):2585-2594. PubMed ID: 35779019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.